TCL Archive In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests February 20, 1976
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006